Peptide record

TPDB92187

Figainin 1 Antibacterial Anticancer Antiparasitic Hemolysis Toxicity modified_plain modified
18 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

Standard-residue backbone model; source-recorded chemical modifications are not verified in these coordinates.

TPDB92187
Figainin 1
Antibacterial Anticancer Antiparasitic Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 Peptipedia CancerPPD 2.0 dbACP dbAMP 3.0 Hemolytic2 PD_Hemolysis ToxinPred 3.0
modified_plain
Yes
A 18-aa modified multi-activity (Antibacterial, Anticancer, Antiparasitic, and other sources) peptide sequence curated from AntiBP3, Peptipedia, CancerPPD 2.0, and other sources, with an available 3D structural model.
C-terminal: Amidation
Sequence
FIGTLIPLALGALTKLFK-NH2
Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
18 reviewed residue count
Amidation Activity
L Activity
Linear Activity
Free Activity
Antimicrobial and Anticancer Activity
Boana raniceps Activity
Evidence Records 3 records
Evidence 1 Activity

Activity

IC50
IC50 = 13.7 µM
Anticancer
13.7 µM

Target

Breast Cancer
MCF-7
Breast

Assay & Model

MTT assay

Source & Reference

dbAMP 3.0 CancerPPD 2.0 dbACP
CancerPPD2
2020

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation. dbAMP 3.0 classified as Anticancer under the disease-associated peptide function classes.
Evidence 2 Activity

Activity

IC50
IC50 = 11.1 µM
Anticancer
11.1 µM

Target

Cervical Cancer
HeLa
Cervix

Assay & Model

MTT assay

Source & Reference

dbAMP 3.0 CancerPPD 2.0 dbACP
CancerPPD2
2020
Evidence 3 Activity

Activity

IC50
IC50 = 10.5 µM
Anticancer
10.5 µM

Target

Skin Cancer
B16-F10
Skin

Assay & Model

MTT assay

Source & Reference

dbAMP 3.0 CancerPPD 2.0 dbACP
CancerPPD2
2020